Login/Sign Up
Palonoget 0.25 mg Injection 5 ml
₹132.3*
MRP ₹147
10% off
₹125*
MRP ₹147
15% CB
₹22 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Palonoget 0.25 mg Injection 5 ml belongs to a class of drugs called antiemetics used to prevent nausea and vomiting during chemotherapy. Nausea is a feeling of uneasiness of the stomach that often comes before vomiting. On the other hand, vomiting is the forcible voluntary or involuntary emptying of stomach contents through the mouth.
Palonoget 0.25 mg Injection 5 ml contains Palonosetron which works by blocking the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting.
Palonoget 0.25 mg Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, you may experience diarrhoea, constipation, dizziness or headache. Most of these side effects of Palonoget 0.25 mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Palonoget 0.25 mg Injection 5 ml or any other medicines, please tell your doctor. Palonoget 0.25 mg Injection 5 ml may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Palonoget 0.25 mg Injection 5 ml. Drive only if you are alert as Palonoget 0.25 mg Injection 5 ml may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.
Palonoget 0.25 mg Injection 5 ml contains Palonosetron which blocks the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting during chemotherapy.
If you are allergic to Palonoget 0.25 mg Injection 5 ml or any other medicines, please tell your doctor. Palonoget 0.25 mg Injection 5 ml may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Palonoget 0.25 mg Injection 5 ml. Drive only if you are alert as Palonoget 0.25 mg Injection 5 ml may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.
Drug-Drug Interaction: Palonoget 0.25 mg Injection 5 ml may interact with antidepressants (citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, escitalopram, duloxetine, venlafaxine), heart-related drugs or high blood pressure (quinidine, amiodarone, nicardipine), antibiotics (moxifloxacin, erythromycin), antiemetic (domperidone), antipsychotic drugs (thioridazine, quetiapine, chlorpromazine, haloperidol).
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have blocked bowel, repeated constipation, heart problems or imbalance of potassium and magnesium in the blood, inform your doctor before taking Palonoget 0.25 mg Injection 5 ml.
Nausea and vomiting: Nausea is a feeling of uneasiness of the stomach that often comes before vomiting. On the other hand, vomiting is the forcible voluntary or involuntary emptying of stomach contents through the mouth. In short, nausea and vomiting are not diseases but are symptoms of many conditions like infections, motion sickness, an early stage of pregnancy, and gastroparesis (slow stomach emptying). There is a receptor located in our brain known as the chemoreceptor zone (CTZ) that controls vomiting.
Alcohol
Caution
The interaction of alcohol with Palonoget 0.25 mg Injection 5 ml is unknown. Please consult a doctor before consuming alcohol with Palonoget 0.25 mg Injection 5 ml.
Pregnancy
Consult your doctor
Palonoget 0.25 mg Injection 5 ml is given to pregnant women only if the doctor thinks the benefits outweigh the risks. Please inform your doctor if you are pregnant.
Breast Feeding
Consult your doctor
Please inform your doctor before taking Palonoget 0.25 mg Injection 5 ml if you are breastfeeding. Palonoget 0.25 mg Injection 5 ml is given to breastfeeding women only if the doctor thinks the benefits are greater than the risks.
Driving
Caution
Palonoget 0.25 mg Injection 5 ml may cause tiredness or dizziness in some people. Therefore, avoid driving or operating heavy machinery if you feel tired or dizzy after taking Palonoget 0.25 mg Injection 5 ml.
Liver
Safe if prescribed
Palonoget 0.25 mg Injection 5 ml may be safe to use in patients with liver problems if prescribed by a doctor. However, if you have any concerns regarding this, please discuss them with your doctor.
Kidney
Safe if prescribed
Palonoget 0.25 mg Injection 5 ml may be safe to use in patients with kidney problems if prescribed by a doctor. However, if you have any concerns regarding this, please discuss them with your doctor.
Children
Caution
Palonoget 0.25 mg Injection 5 ml may be given to children above 1 month in doses as advised by a doctor based on the child's body weight.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes